SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013022
Filing Date
2020-11-06
Accepted
2020-11-06 08:07:47
Documents
58
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20200930x10q.htm   iXBRL 10-Q 2207493
2 EX-10.1 edit-20200930xex10d1.htm EX-10.1 248694
3 EX-31.1 edit-20200930xex31d1.htm EX-31.1 15794
4 EX-31.2 edit-20200930xex31d2.htm EX-31.2 15312
5 EX-32.1 edit-20200930xex32d1.htm EX-32.1 10174
  Complete submission text file 0001558370-20-013022.txt   7234267

Data Files

Seq Description Document Type Size
6 EX-101.SCH edit-20200930.xsd EX-101.SCH 30948
7 EX-101.CAL edit-20200930_cal.xml EX-101.CAL 44566
8 EX-101.DEF edit-20200930_def.xml EX-101.DEF 119354
9 EX-101.LAB edit-20200930_lab.xml EX-101.LAB 359385
10 EX-101.PRE edit-20200930_pre.xml EX-101.PRE 255628
11 EXTRACTED XBRL INSTANCE DOCUMENT edit-20200930x10q_htm.xml XML 1241967
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 201292471
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences